C. Sanvitale

CIS is a potent checkpoint in NK cell–mediated tumor immunity

Rebecca B. Delconte, Tatiana B. Kolesnik, Laura F. Dagley et al. · Nature Immunology · 2016 · 373 citations

Cancer Immunosurveillance, Immunology, Tumor Immunity +5

A New Class of Small Molecule Inhibitor of BMP Signaling

C. Sanvitale, Georgina Kerr, A. Chaikuad et al. · PLoS ONE · 2013 · 237 citations · Full text

Sclerostin, Molecular Biology, Signaling Pathway +17

Structure of the Bone Morphogenetic Protein Receptor ALK2 and Implications for Fibrodysplasia Ossificans Progressiva

A. Chaikuad, I. Alfano, Georgina Kerr et al. · Journal of Biological Chemistry · 2012 · 182 citations · Full text

Mechanobiology, Fop Mutation, Sclerostin +14

Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligases

Daniel M. Pinkas, C. Sanvitale, Joshua C. Bufton et al. · Biochemical Journal · 2017 · 99 citations · Full text

Protein Assembly, Structural Bioinformatics, Molecular Biology +17

Structure–Activity Relationship of 3,5-Diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants

Agustin H. Mohedas, You Wang, C. Sanvitale et al. · Journal of Medicinal Chemistry · 2014 · 94 citations · Full text